Alzheimer's Disease
The latest news about Alzheimer's Disease: headlines, AI summaries and the full story from every source.
- Acumen Pharmaceuticals Expects Phase II Alzheimer's Trial Results in November 2026
- Acumen Pharmaceuticals Shares Plunge Following Failed Alzheimer's Clinical Trial
- INmune Bio Collaborates with Quantum Computing to Advance Alzheimer's Treatment
- Acadia Pharmaceuticals Stock Drops After Mid-Stage Trial Failure
- Actinogen Medical on Track for November XanaMIA Alzheimer's Trial Results
- Acadia Receives FDA Fast Track Designation for Remlifanserin in Alzheimer's Disease Psychosis
- ALZpath's Proprietary pTau217 Antibody Featured in 86 Presentations at AAIC 2026
- IXICO Secures £1.3 Million in New Contracts Covering Nearly Full Revenue Forecast
- Grey Matters Health Rebrands to Focus on Brain Diagnostic Network
- Voyager Therapeutics Announces Preclinical Alzheimer's Gene Therapy Data
- Axsome Therapeutics Stock Rises Over 20% in April Due to FDA Approval for New Indication
- Cyclerion Therapeutics Merges With Korsana Biosciences to Advance Alzheimer’s Drug Development
- Nexalin Advances FDA Alzheimer’s Strategy Following Leadership Meetings in the U.S. and China